先天性心脏病儿童及年轻成人机械主动脉瓣置换术后结局
该单中心回顾性研究纳入2000至2014年接受机械主动脉瓣置换的121例先天性主动脉瓣疾病患者,中位年龄16岁。随访中位5年,1年、5年、10年生存率分别为90.6%±2.8%、85.4%±3.7%、81.5%±4.5%,再次手术的独立预测因素为较年轻年龄。
要点
- 儿童及年轻成人先天性主动脉瓣疾病机械瓣置换术后中期生存良好。
- 较小的瓣膜尺寸(16或17 mm)再次手术风险显著增高。
核心结论
- 先天性心脏病患者机械主动脉瓣置换术具有优异的短期和中期结局,较年轻年龄是再次手术的独立预测因素。
研究设计与样本
- 单中心回顾性研究,纳入2000至2014年接受机械主动脉瓣置换的121例先天性主动脉瓣疾病患者。
- 采用Kaplan-Meier法估计生存率,Cox比例风险模型分析预测因素。
主要发现
- 早期死亡5例(3.9%),随访期间死亡14例。
- 1年、5年、10年生存率分别为90.6%±2.8%、85.4%±3.7%、81.5%±4.5%。
- 免于主动脉瓣再次手术率1年和5年均为98%±1.4%,7年为91.5%±3.9%,10年及末次随访为78.4%±6.9%。
关键数值与推荐
- 所有患者均接受华法林治疗,目标国际标准化比值2.0至3.0。
- 植入瓣膜类型:St Jude瓣膜79例(62%),On-X瓣膜45例(35%),CarboMedics瓣膜3例(2.4%)。
- 中位瓣膜尺寸23 mm(范围21-25 mm)。
- 中位随访5年(范围1.6-9.2年;共600患者年)。
临床怎么用
- 对于先天性主动脉瓣疾病儿童及年轻成人,机械瓣置换术中期结局良好,但需关注较小瓣膜尺寸和较年轻年龄患者的再次手术风险。
- 术后华法林抗凝目标INR 2.0-3.0,血栓栓塞和出血并发症发生率较低。
局限性
- 单中心回顾性研究,样本量有限,可能存在选择偏倚。
- 随访时间中位5年,长期结局需进一步观察。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: There are little recent data on the outcomes of mechanical aortic valve replacement (AVR) in children and young adults with congenital aortic valve disease. We sought to review the survival and associated thromboembolic or bleeding complications after mechanical AVR at a single center. METHODS: Data were retrospectively collected for 121 patients undergoing prosthetic AVR from 2000 to 2014. Kaplan-Meier estimates and Cox proportional hazards were employed. RESULTS: Median age at AVR was 16 years (interquartile range, 12-22.8 years). The valves implanted were the St Jude valve (St Jude Medical Inc, St Paul, Minn) in 79 patients (62%), the On-X valve (On-X Life Technologies Inc, Austin, Tex) in 45 patients (35%), and CarboMedics (Sorin SpA, Milan, Italy) in 3 patients (2.4%). Median valve size was 23 mm (range, 21-25 mm). There were 5 early deaths (3.9%). Median follow-up was 5 years (range, 1.6-9.2 years; 600 patient-years). There were 14 deaths during follow-up. Survival was 90.6% ± 2.8% at 1 year, 85.4% ± 3.7% at 5 years, and 81.5% ± 4.5% at 10 years. Freedom from aortic valve reoperation was 98% ± 1.4% at 1 and 5 years, 91.5% ± 3.9% at 7 years, and 78.4% ± 6.9% at 10 years and at latest follow-up. Univariable analysis identified younger age, lower weight, and use of a 16-mm CarboMedics valve as predictors of reoperation. Valve sizes of 16 or 17 mm have a significantly higher risk of reoperation compared with larger valves (log-rank test, P < .001). At multivariable analysis, only younger age was a significant independent predictor of reoperation (hazard ratio, 0.84; 95% confidence interval, 0.71-0.99; P = .038). All patients were treated with warfarin to a goal international normalized ratio of 2.0 to 3.0. Four patients (3.1%; 0.66% per patient-year) had thromboembolic complications, and 5 patients (3.9%; 0.83% per patient-year) had bleeding events during follow-up. CONCLUSIONS: Mechanical AVR in patients with congenital heart disease has excellent short- and midterm outcomes. Younger age was an independent predictor of reoperation.
引用
- Myers PO, Mokashi SA, Horgan E, et al. Outcomes after mechanical aortic valve replacement in children and young adults with congenital heart disease. J Thorac Cardiovasc Surg. 2018. PMID: 30557950. doi:10.1016/j.jtcvs.2018.08.077
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。